Company Quick10K Filing
Medidata
10-Q 2019-06-30 Filed 2019-08-06
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-30 Filed 2018-10-30
10-Q 2018-06-30 Filed 2018-08-02
10-Q 2018-03-31 Filed 2018-05-04
10-K 2017-12-31 Filed 2018-02-28
10-Q 2017-09-30 Filed 2017-11-03
10-Q 2017-06-30 Filed 2017-08-01
10-Q 2017-03-31 Filed 2017-05-08
10-K 2016-12-31 Filed 2017-02-28
10-Q 2016-09-30 Filed 2016-11-03
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-09
10-K 2015-12-31 Filed 2016-02-29
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-03-02
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-04-30
10-K 2013-12-31 Filed 2014-02-25
10-Q 2013-09-30 Filed 2013-11-04
10-Q 2013-06-30 Filed 2013-08-02
10-Q 2013-03-31 Filed 2013-05-03
10-K 2012-12-31 Filed 2013-03-08
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-07
10-Q 2012-03-31 Filed 2012-05-04
10-K 2011-12-31 Filed 2012-03-13
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-10
10-K 2010-12-31 Filed 2011-03-16
10-Q 2010-09-30 Filed 2010-11-10
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-15
8-K 2019-10-28 Leave Agreement, M&A, Shareholder Rights, Control, Officers, Amend Bylaw, Exhibits
8-K 2019-09-23 Other Events, Exhibits
8-K 2019-08-16 Shareholder Vote, Other Events, Exhibits
8-K 2019-07-23 Earnings, Exhibits
8-K 2019-06-12 Other Events, Exhibits
8-K 2019-06-11 Enter Agreement, Officers, Amend Bylaw, Exhibits
8-K 2019-05-29 Shareholder Vote
8-K 2019-04-30 Earnings, Exhibits
8-K 2019-04-15 Amend Bylaw, Exhibits
8-K 2019-02-12 Earnings, Exhibits
8-K 2019-02-12 Officers
8-K 2018-10-19 Officers, Regulation FD, Exhibits
8-K 2018-10-18 Earnings, Exhibits
8-K 2018-08-01 Sale of Shares
8-K 2018-07-24 Earnings, Exhibits
8-K 2018-06-20 M&A, Exhibits
8-K 2018-06-11 Enter Agreement, Exhibits
8-K 2018-05-30 Shareholder Vote
8-K 2018-04-19 Earnings, Exhibits
8-K 2018-02-20 Officers
8-K 2018-02-08 Earnings, Exhibits

Medidata Financials

MDSO Metrics, Comps, Filings

Quarterly | Annual

Business

Medidata is a global life sciences technology provider, dedicated to improving the way clinical research is designed, conducted, analyzed, and commercialized. Our cloud-based platform of solutions, data analytics, and AI enables efficiency and improves quality throughout clinical development programs by accelerating processes, enhancing decision-making, minimizing operational risk, reducing costs, and transforming trial strategies.

Customers can utilize our entire platform or individual solutions, and can subscribe to our technology on a multi-study or single-study basis. Our revenue is comprised of subscription and professional services, which represent approximately 85% and 15% of our business, respectively. Our subscription business model provides us with a recurring revenue stream that we believe delivers greater revenue visibility than perpetual software licensing models.

The Medidata Cloud is the Intelligent Platform for Life Sciences, transforming clinical development and converting complex data into cutting-edge insights. It provides a unified platform for demonstrating treatment efficacy and safety, supporting regulatory approval, achieving peak revenue faster, improving outcomes for patients, providers, and payers, and paving the way for the increasingly more precise therapies of the future.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Ceridian (CDAY) 7,310 45% 75.7 1% 5,436 3,583 602 270 80 92 6,953
Anaplan (PLAN) 6,867 73% -65.5 -18% 618 324 250 183 -113 -100 6,556
Elastic (ESTC) 6,666 71% -45.0 -19% 767 334 342 243 -148 -141 6,359
MongoDB (MDB) 6,619 70% -71.3 -15% 735 516 298 208 -113 -91 6,467
Hubspot (HUBS) 6,559 81% -293.8 -4% 1,479 851 633 511 -55 -22 6,325
RealPage (RP) 6,189 75% 43.8 2% 2,292 1,143 733 548 44 138 6,060
Avalara (AVLR) 6,080 70% -250.8 -5% 725 261 275 192 -35 -22 5,633
SolarWinds (SWI) 5,945 72% 38.0 -0% 5,156 2,563 906 654 -9 202 7,679
Medidata (MDSO) 5,643 74% 78.2 4% 1,024 363 685 504 44 70 5,497
National Instruments (NATI) 5,573 75% 29.6 6% 1,628 466 986 740 104 181 5,351
Manhattan Associates (MANH) 5,367 41% 39.7 25% 380 229 609 252 95 132 5,254
Paylocity Holding (PCTY) 5,300 67% 42.0 4% 1,598 1,289 494 333 58 99 4,164
Nutanix (NTNX) 4,920 76% -7.3 -41% 1,866 1,803 1,238 935 -756 -640 4,683
Nuance Communications (NUAN) 4,785 57% 13.3 4% 5,366 3,193 1,823 1,043 214 480 6,368
Smartsheet (SMAR) 4,461 81% -67.9 -9% 775 248 192 155 -68 -58 3,946
Blackbaud (BLKB) 4,435 54% 46.0 1% 1,710 1,329 884 479 20 101 4,668
Pivotal Software (PVTL) 4,133 68% -42.0 -5% 1,939 575 577 395 -93 -79 3,311
Sina (SINA) 3,884 0% 5,886 2,123 0 0 0 0 2,241
ACI Worldwide (ACIW) 3,810 53% 16.7 3% 3,341 2,282 1,178 630 99 307 5,119

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash222645585937333739192222535274071436350886465949011613424323212689113116146
Accounts Receivable281923313632424842414666625168809487917890115115102111106111133137163171178198
Inventory
PP&E991099942111424674041407140424492525554105637182151939397189111114
Assets1591661902012092122252302415465735615715876226446726846876747127868188278899141,0461,0761,1038689139971,024
Accounts Payable12422431248654463262116712258777811
Long-Term Debt288288288288288288288288288288288288288288288288288
Liabilities908786879083837680331348336337338358373384382403380397407416416446446549554541274282360363
Stockholders' Equity6879104114119129142154161215226225234249265271288302284294315379402411443468497522561594631637660
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue504647505456596375717577898689929810399104115120124127137140141149156163167174180
Cost of Revenue131413151716161718171921212122222323222529293031323233363842434650
Gross Profit373334364140424651545656646567707580778086919596105109109113118121124128131
R&D
SG&A1918192023222327303143383839384548454445464849545655566265667680
Tax00110010000000003-013431261112-6-6
Net Income1071944476751-2205025765711108131410171114118
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating152368-33262020-624222117122831122610402238313051933624
Cash Investing-11127-4-32-60-19-151-19227-11-38-919-39-7-1033-53-8-13-17-26-15-20-5-1252132016
Cash Financing043-1252-52842-18-471-4-1-1-35-74-12-97299-110-283-22-10